Astec Lifesciences shines on concluding sale of its 100% stake in ACCPL

18 Feb 2016 Evaluate

Astec Lifesciences is currently trading at Rs. 193.00, up by 7.60 points or 4.10% from its previous closing of Rs. 185.40 on the BSE.

The scrip opened at Rs. 188.00 and has touched a high and low of Rs. 195.10 and Rs. 188.00 respectively. So far 4352 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 304.00 on 21-Jul-2015 and a 52 week low of Rs. 105.20 on 26-Feb-2015.

Last one week high and low of the scrip stood at Rs. 195.00 and Rs. 173.20 respectively. The current market cap of the company is Rs. 375.68 crore.

The promoters holding in the company stood at 62.28% while Institutions and Non-Institutions held 0.14% and 37.58% respectively.

Astec Lifesciences has completed the sale of 100% of the total paid-up equity share capital held in ACCPL to Ashok Hiremath and Varun Hiremath. Consequent to the completion of the sale, ACCPL has ceased to be a subsidiary of the company.

Astec Lifesciences is a producer of agrochemicals and pharmaceutical intermediates. It was established in 1994 with a focus on the Agrochemical and Pharmaceutical industries.

Astec Lifesciences Share Price

1060.65 8.50 (0.81%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
UPL 566.10
BASF India 5635.90
PI Industries 4115.15
Bayer CropScience 5726.95
Sumitomo Chemical India 513.95
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.